StockGlow

Concord Drugs Limited (CONCORD.BO)

Concord Drugs Limited engages in the manufacture and sale of pharmaceutical formulations in India.

73.99-0.01%Healthcare
Compare CONCORD.BO with
StockGlow Score
32
Leaning Bearish
BearishBullish
1 year ago+32.1%

The outlook

Concord Drugs Limited currently reads as leaning bearish based on below its 50- & 200-day averages, 57% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range57% of the way from its 52-week low to high
Market cap
$974.8M
52-wk high
92.52
52-wk low
49.00
50-day avg
75.96
200-day avg
77.72
Trailing P/E
77.9

Similar stocks

BERLDRG.BOBeryl Drugs Limited$20.25-1.22%GODAVARI.BOGodavari Drugs Limited$106.05-0.42%COLINZ.BOColinz Laboratories Limited$82.00+2.50%ANG.BOANG Lifesciences India Limited$36.00+0.73%BDH.BOBDH Industries Limited$563.25+0.33%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy